Tl. Jetton et al., TARGETED ONCOGENESIS OF HORMONE-NEGATIVE PANCREATIC-ISLET PROGENITOR CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(15), 1998, pp. 8654-8659
Transgenic mice containing an upstream glucokinase (beta GK) promoter-
simian virus 40 T antigen (Tag) fusion gene develop neuroendocrine tum
ors primarily in the pancreas, gut, and pituitary. Pancreatic tumors f
rom a line with delayed tumorigenesis were of two different types: ins
ulinomas and noninsulinomas. The noninsulinomas are often periductal i
n location, express none of the four major islet peptide hormones, Glu
t-2, Pdx1, tyrosine hydroxylase, Pax4, Pax6, or Nkx6.1, but do express
glucokinase, Sur1, Isl1, Hnf3 beta, Hnf6, Beta2/NeuroD, and Nkx2.2. C
ells from two different noninsulinoma tumors, when adapted to culture,
began to express either insulin, glucagon, or somatostatin. Given the
partial gene expression repertoire of the noninsulinoma tumors, their
apparent periductal origin, and the ability of these cells to partial
ly cytodifferentiate in culture, we suggest that these tumors are deri
ved from islet progenitor cells. Thus, beta GK-Tag transgenic mice pro
vide a new model system for studying the events that occur during both
islet cell neogenesis and normal embryonic development.